CANF Stock Analysis: Buy, Sell, or Hold?
CANF - Can-Fite BioPharma Ltd. American Depositary Shares, each representing three hundred (300) Ordinary Shares
$4.01
-0.09 (-2.20%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Get Alerted When CANF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CANF shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CANF shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CANF is currently trading at $4.01, which is considered slightly high relative to its 30-day fair value range of $1.19 to $4.89.
Technical Outlook: Technically, CANF is in a strong uptrend. Immediate support is located at $3.87, while resistance sits at $4.64.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $3.50. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CANF is in a strong uptrend. Immediate support is located at $3.87, while resistance sits at $4.64.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $3.50. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$1.19 -
$4.89
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
56.3%
Protect Your Profits
Holding CANF? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 14.6% above Wall St target ($3.50)
- CAUTION: 5-day price weakness (-10.3%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.19 -
$4.89
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$3.87
Resistance Level
$4.64
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-102.50
Wall Street Target
$3.50
(-14.6%)
Revenue Growth (YoY)
-36.1%
Last updated: January 30, 2026 9:43 PM ET
Data refreshes hourly during market hours. Next update: 10:43 PM
Data refreshes hourly during market hours. Next update: 10:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CANF showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$85 | 55 HOLD |
Advanced CANF Option Strategies
Professional options setups generated by AI based on today's CANF price and gamma walls.
